Clinical trials recruiting in Shaoguan, China
10
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 1Phase 3 6Phase 4 1Not applicable 2
Conditions recruiting in Shaoguan, China
Recruiting trials in Shaoguan, China
- A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
- A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI)
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- ASPIrin in Reducing Events in Dialysis ( ASPIRED )
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns
- ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
- JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
- LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Common questions
How many clinical trials are recruiting in Shaoguan, China?
10 recruiting trials have at least one study site in Shaoguan, China.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.